Categories News Press Releases Archives 2025 June May April March February January 2024 December November October September August July June May April March February January 2023 December November October September August July June April March February January 2022 December November October September August June May March February January 2021 December November October September August May April February Jan 31 Voices on Value: Supporting People Impacted by Rare Disease through an Effective Policy Landscape Read More Share:| | | Jan 16 UCB Announces U.S. Availability of 320 mg/2 mL Single-Injection Administration Option for BIMZELX® (bimekizumab-bkzx) Read More Share:| | |